+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Amino Acid Metabolism Disorders Treatment Market by Treatment (Gene Therapy, Liver Transplant, Medication), Indication (Maple Syrup Urine Disease, Phenylketonuria), End-User - Forecast 2024-2030- Product Image
Global Amino Acid Metabolism Disorders Treatment Market by Treatment (Gene Therapy, Liver Transplant, Medication), Indication (Maple Syrup Urine Disease, Phenylketonuria), End-User - Forecast 2024-2030- Product Image
Sale

Global Amino Acid Metabolism Disorders Treatment Market by Treatment (Gene Therapy, Liver Transplant, Medication), Indication (Maple Syrup Urine Disease, Phenylketonuria), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5968198
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Amino Acid Metabolism Disorders Treatment Market size was estimated at USD 796.90 million in 2023, USD 851.17 million in 2024, and is expected to grow at a CAGR of 7.31% to reach USD 1,306.41 million by 2030.

Amino acid metabolism disorders treatment includes interventions used to manage and treat conditions where the body cannot properly process amino acids. Amino acids are the building blocks of proteins and are crucial for various body functions. When these disorders occur, it can lead to an accumulation of amino acids or their byproducts in the body, which can be toxic and lead to various health issues. The rising prevalence of genetic disorders is driving the need for amino acid metabolism disorders treatments.

Increased awareness about genetic disorders and mandatory newborn screening programs across numerous countries have led to the early detection of amino acid metabolism disorders, which are driving the need for prompt treatment associated with amino acid metabolism disorders. The high cost of treatment and lack of awareness in low-income countries hampers market growth. Rising focus on research leads to the development of more effective and targeted treatments that manage symptoms better and extend life expectancy are expected to create opportunities for market growth.

Regional Insights

In the Americas, there is a robust healthcare infrastructure that supports the diagnosis and treatment of rare metabolic disorders, including those involving amino acid metabolism. Advances in genetic testing and newborn screening have significantly improved early detection rates, leading to timely treatment interventions. The market is supported by strong regulatory frameworks and the presence of leading pharmaceutical companies engaged in developing treatments for these disorders. Awareness and healthcare spending in this region are relatively high, contributing to the market's growth. The APAC region has seen significant growth in healthcare sectors, particularly in countries such as China, Japan, and India.

Awareness about amino acid metabolism disorders is growing, and with it, the demand for treatment solutions is also rising. Europe leads within this region regarding the market for treating amino acid metabolism disorders, driven by well-established healthcare systems, widespread newborn screening programs, and strong regulatory support for orphan drugs. Conversely, the Middle East and Africa present a mixed picture with significant disparities in healthcare infrastructure and access across countries. While some Middle Eastern countries with high incomes have better healthcare facilities, African nations often face challenges related to limited resources and lack of specialized care, which can impede the growth of the treatment market in these areas.

Market Trends by Segment

  • Treatment: Growing usage of medications to eliminate excess amino acids from the body
  • End-User: Growing accessibility of amino acid metabolism disorders treatment through hospitals & clinics for diagnosing and treating cases of amino acid metabolism disorders

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

PTC Therapeutics to Showcase New Advances in Phenylketonuria Treatment at SSIEM 2023

PTC Therapeutics, Inc. is set to present significant findings from its APHENITY clinical trial at the Society for the Study of Inborn Errors of Metabolism (SSIEM),l. The company revealed Phase 3 results of the APHENITY trial, which focused on the oral medication Sepiapterin for Phenylketonuria (PKU) management. These findings indicate sustained control of mean blood phenylalanine levels and increased protein intake among patients treated with Sepiapterin. Moreover, PTC will also discuss its ongoing research into aromatic l-amino acid decarboxylase (AADC) deficiency through various platforms at the event.

Key Company Profiles

The report delves into recent significant developments in the Amino Acid Metabolism Disorders Treatment Market, highlighting leading vendors and their innovative profiles. These include Abeona Therapeutics Inc., Alnylam Pharmaceuticals, Inc., American Gene Technologies Inc., Amgen Inc., AnGes, Inc., Astellas Gene Therapies, Beacon Therapeutics Limited, Biogen Inc., Cellectis SA, Editas Medicine, Inc., F. Hoffmann-La Roche Ltd, Ionis Pharmaceuticals, Inc., Merck KGaA, Mustang Bio, Inc., Novartis AG, and Pfizer Inc.

This research report offers invaluable insights into various crucial aspects of the Amino Acid Metabolism Disorders Treatment Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing number of diagnosed cases of amino acid metabolism disorders,
5.1.1.2. Enhanced supportive regulatory policies addressing rare metabolic disorders
5.1.2. Restraints
5.1.2.1. High cost of treatment limiting patient accessibility
5.1.3. Opportunities
5.1.3.1. Development of enhanced diagnostic tools and genetic testing technologies
5.1.3.2. Ongoing research aimed at discovering new treatments for amino acid metabolism disorders
5.1.4. Challenges
5.1.4.1. Complexities in product development for amino acid metabolism disorders treatment
5.2. Market Segmentation Analysis
5.2.1. Treatment: Growing usage of medications to eliminate excess amino acids from the body
5.2.2. End-User: Growing accessibility of amino acid metabolism disorders treatment through hospitals & clinics for diagnosing and treating cases of amino acid metabolism disorders
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Amino Acid Metabolism Disorders Treatment Market, by Treatment
6.1. Introduction
6.2. Gene Therapy
6.3. Liver Transplant
6.4. Medication
6.5. Supplementation
7. Amino Acid Metabolism Disorders Treatment Market, by Indication
7.1. Introduction
7.2. Maple Syrup Urine Disease
7.3. Phenylketonuria
8. Amino Acid Metabolism Disorders Treatment Market, by End-User
8.1. Introduction
8.2. Ambulatory Surgery Centers
8.3. Hospitals & Clinics
9. Americas Amino Acid Metabolism Disorders Treatment Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Amino Acid Metabolism Disorders Treatment Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Amino Acid Metabolism Disorders Treatment Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. PTC Therapeutics to Showcase New Advances in Phenylketonuria Treatment at SSIEM 2023
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. AMINO ACID METABOLISM DISORDERS TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. AMINO ACID METABOLISM DISORDERS TREATMENT MARKET DYNAMICS
FIGURE 7. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 8. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. AMINO ACID METABOLISM DISORDERS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY GENE THERAPY, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY LIVER TRANSPLANT, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY LIVER TRANSPLANT, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY SUPPLEMENTATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY SUPPLEMENTATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY MAPLE SYRUP URINE DISEASE, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY MAPLE SYRUP URINE DISEASE, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY PHENYLKETONURIA, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY PHENYLKETONURIA, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. AMERICAS AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 30. AMERICAS AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 31. AMERICAS AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 32. AMERICAS AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 33. AMERICAS AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 34. AMERICAS AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 35. AMERICAS AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 36. AMERICAS AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 37. ARGENTINA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 38. ARGENTINA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 39. ARGENTINA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 40. ARGENTINA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 41. ARGENTINA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 42. ARGENTINA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 43. BRAZIL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 44. BRAZIL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 45. BRAZIL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 46. BRAZIL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 47. BRAZIL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 48. BRAZIL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 49. CANADA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 50. CANADA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 51. CANADA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 52. CANADA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 53. CANADA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 54. CANADA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 55. MEXICO AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 56. MEXICO AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 57. MEXICO AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 58. MEXICO AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 59. MEXICO AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 60. MEXICO AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 61. UNITED STATES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 62. UNITED STATES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 63. UNITED STATES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 64. UNITED STATES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 65. UNITED STATES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 66. UNITED STATES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 67. UNITED STATES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 68. UNITED STATES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 70. ASIA-PACIFIC AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 72. ASIA-PACIFIC AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 74. ASIA-PACIFIC AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 76. ASIA-PACIFIC AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 77. AUSTRALIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 78. AUSTRALIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 79. AUSTRALIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 80. AUSTRALIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 81. AUSTRALIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 82. AUSTRALIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 83. CHINA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 84. CHINA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 85. CHINA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 86. CHINA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 87. CHINA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 88. CHINA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 89. INDIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 90. INDIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 91. INDIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 92. INDIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 93. INDIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 94. INDIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 95. INDONESIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 96. INDONESIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 97. INDONESIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 98. INDONESIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 99. INDONESIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 100. INDONESIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 101. JAPAN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 102. JAPAN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 103. JAPAN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 104. JAPAN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 105. JAPAN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 106. JAPAN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 107. MALAYSIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 108. MALAYSIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 109. MALAYSIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 110. MALAYSIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 111. MALAYSIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 112. MALAYSIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 113. PHILIPPINES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 114. PHILIPPINES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 115. PHILIPPINES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 116. PHILIPPINES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 117. PHILIPPINES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 118. PHILIPPINES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 119. SINGAPORE AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 120. SINGAPORE AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 121. SINGAPORE AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 122. SINGAPORE AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 123. SINGAPORE AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 124. SINGAPORE AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 125. SOUTH KOREA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 126. SOUTH KOREA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 127. SOUTH KOREA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 128. SOUTH KOREA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 129. SOUTH KOREA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 130. SOUTH KOREA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 131. TAIWAN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 132. TAIWAN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 133. TAIWAN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 134. TAIWAN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 135. TAIWAN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 136. TAIWAN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 137. THAILAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 138. THAILAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 139. THAILAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 140. THAILAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 141. THAILAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 142. THAILAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 143. VIETNAM AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 144. VIETNAM AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 145. VIETNAM AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 146. VIETNAM AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 147. VIETNAM AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 148. VIETNAM AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 157. DENMARK AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 158. DENMARK AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 159. DENMARK AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 160. DENMARK AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 161. DENMARK AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 162. DENMARK AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 163. EGYPT AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 164. EGYPT AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 165. EGYPT AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 166. EGYPT AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 167. EGYPT AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 168. EGYPT AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 169. FINLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 170. FINLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 171. FINLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 172. FINLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 173. FINLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 174. FINLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 175. FRANCE AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 176. FRANCE AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 177. FRANCE AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 178. FRANCE AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 179. FRANCE AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 180. FRANCE AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 181. GERMANY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 182. GERMANY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 183. GERMANY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 184. GERMANY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 185. GERMANY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 186. GERMANY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 187. ISRAEL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 188. ISRAEL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 189. ISRAEL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 190. ISRAEL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 191. ISRAEL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 192. ISRAEL AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 193. ITALY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 194. ITALY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 195. ITALY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 196. ITALY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 197. ITALY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 198. ITALY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 199. NETHERLANDS AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 200. NETHERLANDS AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 201. NETHERLANDS AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 202. NETHERLANDS AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 203. NETHERLANDS AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 204. NETHERLANDS AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 205. NIGERIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 206. NIGERIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 207. NIGERIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 208. NIGERIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 209. NIGERIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 210. NIGERIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 211. NORWAY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 212. NORWAY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 213. NORWAY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 214. NORWAY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 215. NORWAY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 216. NORWAY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 217. POLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 218. POLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 219. POLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 220. POLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 221. POLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 222. POLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 223. QATAR AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 224. QATAR AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 225. QATAR AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 226. QATAR AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 227. QATAR AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 228. QATAR AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 229. RUSSIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 230. RUSSIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 231. RUSSIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 232. RUSSIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 233. RUSSIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 234. RUSSIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 236. SAUDI ARABIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 238. SAUDI ARABIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 240. SAUDI ARABIA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 242. SOUTH AFRICA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 244. SOUTH AFRICA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 246. SOUTH AFRICA AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 247. SPAIN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 248. SPAIN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 249. SPAIN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 250. SPAIN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 251. SPAIN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 252. SPAIN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 253. SWEDEN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 254. SWEDEN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 255. SWEDEN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 256. SWEDEN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 257. SWEDEN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 258. SWEDEN AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 259. SWITZERLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 260. SWITZERLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 261. SWITZERLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 262. SWITZERLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 263. SWITZERLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 264. SWITZERLAND AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 265. TURKEY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 266. TURKEY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 267. TURKEY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 268. TURKEY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 269. TURKEY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 270. TURKEY AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2018-2023 (USD MILLION)
TABLE 278. UNITED KINGDOM AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY TREATMENT, 2024-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 280. UNITED KINGDOM AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 282. UNITED KINGDOM AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 283. AMINO ACID METABOLISM DISORDERS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 284. AMINO ACID METABOLISM DISORDERS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • Abeona Therapeutics Inc.
  • Alnylam Pharmaceuticals, Inc.
  • American Gene Technologies Inc.
  • Amgen Inc.
  • AnGes, Inc.
  • Astellas Gene Therapies
  • Beacon Therapeutics Limited
  • Biogen Inc.
  • Cellectis SA
  • Editas Medicine, Inc.
  • F. Hoffmann-La Roche Ltd
  • Ionis Pharmaceuticals, Inc.
  • Merck KGaA
  • Mustang Bio, Inc.
  • Novartis AG
  • Pfizer Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages189
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 851.17 Million
Forecasted Market Value ( USD ) by 2030 $ 1306.41 Million
Compound Annual Growth Rate7.3%
Regions CoveredGlobal
No. of Companies Mentioned16

Related Topics

Related Reports

Amino Acid Metabolism Disorders Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Amino Acid Metabolism Disorders Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 98 Pages
  • Global
From
Phenylketonuria - Market Insight, Epidemiology And Market Forecast - 2032 - Product Image

Phenylketonuria - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • 128 Pages
  • Global
From
Phenylketonuria - Pipeline Insight, 2024 - Product Image

Phenylketonuria - Pipeline Insight, 2024

  • Clinical Trials
  • 110 Pages
  • Global
From
Phenylketonuria Treatment Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F - Product Image

Phenylketonuria Treatment Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F

  • Report
  • 190 Pages
  • Global
From
Maple Syrup Urine Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Image

Maple Syrup Urine Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • 128 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.